生物植入物市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品類型、材料、最終用戶、地區和競爭細分，2019-2029F

2023 年全球生物植入物市場估值為 1,253 億美元，預計在預測期內將強勁成長，到 2029 年複合年成長率為 10.70%。或幫助骨骼癒合。植入物織物的主要作用是透過最大限度地減少骨-植入物界面的移動來為骨折提供穩定性並促進有機骨恢復。生物植入物中常用的金屬是鈦及其合金，以其卓越的耐腐蝕性、高能量和生物相容性而聞名，使其廣泛用作外科植入物。生物植入物是用來替代、支撐或增強生物結構的假體。它們由各種生物合成材料（例如膠原蛋白）和組織工程產品（例如人造皮膚）組成。生物植入物分為三大類：生物植入物，包括生物人工器官、細胞治療及組織工程；生物化植入物，包括體內細胞襯裡、技術植入物和生物混合系統；以及生物功能化植入物，包括表面功能化植入物和藥物洗脫支架。在耳鼻喉科領域，生物植入物取得了非常成功的手術效果，有效調節了患者的生理功能，使他們能夠過著有成效的生活。

主要市場促進因素

老年人口增加

對微創手術的偏好不斷上升

擴大治療用途範圍

技術進步

主要市場挑戰

植入手術成本高昂

生物材料對接受體的適應

主要市場趨勢

生活方式壓力導致慢性病增加

基因工程生物材料

細分市場洞察

產品類型洞察

材料洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球生物植入物市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 依產品類型（心血管植體、脊椎植入物、骨科植體、牙科植體、眼科植體和其他植體）
  • 依材料（生物材料金屬合金、陶瓷、聚合物和其他材料）
  • 按最終使用者（醫院診所、門診手術中心、其他）
  • 按地區
  • 按公司分類 (2023)
• 市場地圖

第 6 章：北美生物植入物市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 依產品類型
  • 按材質
  • 按最終用戶
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第 7 章：歐洲生物植入物市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 依產品類型
  • 按材質
  • 按最終用戶
  • 按國家/地區
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第 8 章：亞太地區生物植入物市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 依產品類型
  • 按材質
  • 按最終用戶
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第 9 章：南美洲生物植入物市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 依產品類型
  • 按材質
  • 按最終用戶
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲生物植入物市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 依產品類型
  • 按材質
  • 按最終用戶
  • 按國家/地區
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 促進要素
• 挑戰

第 12 章：市場趨勢發展

• 近期發展
• 併購
• 產品發布

第 13 章：全球生物植入物市場：SWOT 分析

第 14 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第15章：競爭格局

• BIOTRONIK SE Co. KG
• Invibio Limited
• Wright MedicalGroup NV
• Edwards Lifesciences Corporation
• MiMeDX Group Inc.
• Stryker Corporation
• Endo International plc
• Smith Nephews plc
• Zimmer Biomet Holdings Inc
• Ethicon Inc.

第 16 章：策略建議

第 17 章：關於我們免責聲明

Global Bio-Implants Market was valued at USD 125.30 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 10.70% through 2029. Bio-implants are biosynthetic materials utilized in medical applications for the purpose of bone repair, replacement, or aiding in bone healing. The primary role of implant fabric is to provide stability to bone fractures and facilitate organic bone recovery by minimizing movement at the bone-implant interface. The metals commonly used in bio-implants are titanium and its alloys, known for their exceptional corrosion resistance, high energy, and biocompatibility, making them widely used as surgical implants. Bio-implants are prostheses employed to replace, support, or enhance biological structures. They consist of various biosynthetic materials such as collagen and tissue-engineered products like artificial skin. Bio-implants are categorized into three major groups: biological implants encompassing bioartificial organs, cell therapy, and tissue engineering; biologized implants comprising in-vivo cell lining, technical implants, and biohybrid systems; and biofunctionalized implants including surface-functionalized implants and drug-eluting stents. In the field of ENT, bio-implants have yielded highly successful surgical outcomes, effectively regulated patients' physiological functions and enabling them to lead productive lives.

Key Market Drivers

Rising Geriatric Population

The population of elderly individuals, aged 80 and above, is on the rise due to improved living standards and advancements in the medical field. Older adults tend to avoid lengthy medical treatments, which is expected to drive the demand for bio-implants in this age group in the coming years. Surgeons often avoid major operations in older patients due to concerns about medical complications, which contributes to market growth. The most common ailments among geriatric individuals are related to eyesight and joint issues. Addressing these conditions can be achieved through the use of retinal bioimplants and knee or hip joint replacements. Current market trends suggest that the elderly population is set to increase, with more noticeable effects in nations with a high HDI such as Korea and the United States. Considering the frequent use of bio-implants in orthopedic treatments, this development holds significant implications for the market. Hip fractures rank among the most prevalent catastrophic injuries among the elderly, often necessitating immediate surgery and anesthesia. Consequently, patients spend several weeks in the hospital, resulting in the utilization of 1.5 million hospital bed days each year. As per NICE recommendations, surgical intervention should be conducted on the same day as hospital admission or the following day. This approach is informed by the understanding that being bedridden with a hip fracture is an unpleasant, distressing, and debilitating experience for patients, who are unable to mobilize until the procedure is completed. Thus, the expanding geriatric population is driving the growth of the Bio-implant Market.

Rising Preference toward Minimally Invasive Surgeries

A significant trend observed in the bioimplants market is the increasing demand for minimally invasive surgeries. The ability to create precise incisions for accessing surgical points is a significant advantage of these procedures. Minimally invasive surgeries enable endoscopic and laparoscopic bio-implanting procedures, resulting in reduced pain and faster postoperative recovery.

Minimally invasive surgeries offer significant benefits in terms of reducing post-surgical complications, promoting quick recovery, and shortening hospital stays. Procedures such as laser surgery, endoscopy, and laparoscopy involve small incisions, effectively minimizing pain and morbidity while enhancing postoperative recovery. The convenience of minimally invasive surgeries also drives the utilization of small bioimplants, smart tools, and devices. As a result, the preference for minimally invasive surgeries is poised to grow, making it a key trend in the bioimplants market in the coming years.

Increasing Range of Therapeutic Uses

Bio-implants have a wide range of therapeutic applications in various domains such as orthopedics, cardiology, dentistry, neurology, and more. They play a crucial role in enhancing both the duration and quality of human life. Moreover, bio-implants are utilized in the treatment of skin burns or wounds resulting from surgical procedures. Additionally, the increasing aging population, which is more susceptible to chronic conditions like cardiovascular disease, orthopedic disorders, endovascular diseases, and dental disorders, is one of the key drivers behind the growth of the Bio-Implants Market. Numerous chronic diseases, such as gout, congenital and neuropathic disorders, and cardiovascular diseases (CVD), have sedentary lifestyles as their primary contributing factor. Consequently, the global market for bio-implants has witnessed significant growth.

Technological advancement

Technological advancements in bio-implant manufacturing, such as 3D printing, laser technology, and nanotechnology, have significantly enhanced the biocompatibility of these products. A key contributing factor to these advancements is the increased allocation of healthcare funding by governments worldwide. Several governmental organizations are collaborating with healthcare research firms and medical equipment manufacturers to introduce novel and more efficacious devices to the market. Post-acute myocardial heart attack, the inclusion of extracellular vesicles from stem cells in bio implants has shown improved cardiac performance. The growing prevalence of cardiovascular diseases globally serves as the primary driver for the expansion of this market segment. Moreover, the increasing geriatric population worldwide presents a promising avenue for market growth throughout the forecast period. For instance, as per a 2021 essay published by the American Heart Association, approximately 40,000 children undergo congenital heart surgery annually in the United States.

Key Market Challenges

High Cost of Implanting Procedures

Implant procedures are significantly expensive due to the high costs associated with importing implant materials and the expertise required by skilled surgeons. For instance, dental implants for a single tooth typically fall within the higher price range. Similarly, the costs of treating chronic conditions with essential organ implants are exorbitant. These include retinal implants, cardiac stents, spinal implants, and cosmetic implants, all of which have the potential to restrict market growth.

Biomaterial Adaptation to Receptive Bodies

The efficacy of embedded implants in the human body is directly correlated with the body's adaptation to the material. The likelihood of immune reactions in the body plays a crucial role in assessing this efficacy. Infections resulting from implant materials have been reported due to bacterial adhesion to biomaterials used for implants, which impacts market growth. Allergic reactions of the body to foreign implanted materials cause discomfort to patients. Treatment in such cases often involves the removal of the implanted material and its replacement with other materials compatible with the body. Challenges arise at the implantation site due to material rejection by the human body, which manifests as inflammation and infections in and around the implant site.

Key Market Trends

Increasing Chronic Diseases due to Stressful Lifestyles

Chronic diseases affecting the heart, kidneys, and liver are on the rise due to stressful lifestyles and unhealthy habits. These conditions often require treatments such as organ and tissue transplantation, as well as the use of bio-implants. Additionally, degenerative bone and joint problems pose significant challenges. The increasing global geriatric population presents a substantial opportunity for the growth of the bio-implants market. Orthopedic biological implants are preferred for joint replacements and strengthening, addressing deformities caused by natural, accidental, or congenital factors. The utilization of implants, such as pacemakers and stents, for treating cardiovascular diseases is also increasing. This growth is driven by the need for effective control and treatment of heart ailments in the aging population worldwide.

Genetically Engineered Biomaterials

Naturally occurring biomaterials, such as proteins, undergo selective modifications for tissue engineering purposes. This primarily involves cell adhesion, protein fusions, and their applications in gene delivery, cell encapsulation, coating, and drug delivery. These advancements are poised to enhance the growth prospects of the market. Genetically engineered biomaterials involve sequencing processes based on genetics, structure, molecular weights, and fusion chemistries. A surge in the production of biomaterials using physical and chemical combinations in genetic engineering is anticipated. This focused production of biomaterials through intrinsic research contributes to the improvement in the effectiveness of implants. One significant opportunity driving the expansion of the cosmetic biomaterial market is research aimed at developing artificial skin using specialized biomaterials. Various forms of sponges that combine fibrillar collagen and gelatin are under evaluation. The evaluation encompasses in vitro cellular responses and in vivo tissue reactions, including experimentation in a whole organism, such as in vivo cell lining.

Segmental Insights

Product TypeInsights

Based on the product type, the market is categorized into different segments including cardiovascular implants, spinal implants, orthopaedic implants, dental implants, ophthalmic implants, and other implants. Among these, cardiovascular implants dominate the market due to the increasing prevalence of cardiovascular diseases. The geriatric population is also growing, creating further growth opportunities in this segment. Various factors such as smoking, sedentary lifestyle of the young population, and high blood pressure contribute to the development of cardiovascular diseases. Bioimplants are commonly used for treating such conditions, with surgery being the preferred method for most patients. As a result, the market is expected to experience significant expansion throughout the forecast period, as indicated by the analysis.

Material Insights

Based on the material, the biomaterial metal alloys category emerged as the dominant segment in the bio-implant market in 2023 and is projected to maintain its position throughout the forecast period. Key drivers for the category include notable advantages such as superior tensile strength and corrosion resistance compared to ceramics and other materials. Noteworthy applications of biomaterial metals include dental implants, joint replacement implants, and pacemaker cases. Conversely, ceramic implants are anticipated to experience rapid growth during the forecast period. Ceramics have garnered significant attention due to their ability to fulfil crucial mechanical functions for tissue repair. Furthermore, the potential of bio-ceramics to stimulate bone regeneration tissues is expected to drive their adoption in the coming years.

Regional Insights

North America has a dominant presence in the Bio-Implants Market. It is observed to hold a significant share and is projected to maintain this trend in the forecast period without any notable variations. The market growth is primarily driven by the growing incidence of chronic illnesses and the availability of advanced healthcare infrastructure. Europe is the second largest market for bio-implants, attributed to government funding and support, a rise in the prevalence of orthopedic illnesses, and increased RD efforts. For instance, many pacemaker manufacturers focus on developing MRI-conditional and leadless pacemakers. Moreover, the increasing prevalence of cardiovascular diseases (CVD) leads to a higher number of CVD procedures, contributing to market expansion. Asia Pacific is expected to witness the fastest growth throughout the forecast period, primarily due to the rising prevalence of spinal cord injuries. This can be attributed to a significant increase in the number of traffic accidents. According to a 2019 study by Tokyo's Keio University, more than 100,000 individuals in Japan suffer from paralysis caused by spinal cord injuries. However, the recent approval of iPS technology in the country is likely to offer potential for bio-implant market growth in the future, providing assistance to such patients. Therefore, these aforementioned factors are anticipated to propel market growth in the region during the forecast period.

Key Market Players

BIOTRONIK SE Co. KG

Invibio Limited

Wright Medical Group N.V.

Edwards Lifesciences Corporation

MiMeDX Group Inc.

Stryker Corporation

Endo International plc

Smith Nephew plc

Zimmer Biomet Holdings Inc

Ethicon Inc.

Report Scope:

In this report, the Global Bio-Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-Implants Market,By Product Type:

• Cardiovascular Implants
• Spinal Implants
• Orthopedic Implants
• Dental Implants
• Ophthalmic Implants
• Other Implants

Bio-Implants Market,By Material:

• Biomaterial Metal Alloys
• Ceramics
• Polymers
• Other Materials

Bio-Implants Market,By End User:

• Hospitals Clinics
• Ambulatory Surgical Centres
• Others

Bio-Implants Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio-Implants Market.

Available Customizations:

Global Bio-Implants marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validations
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Bio-Implants Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Product Type (Cardiovascular Implants, Spinal Implants, Orthopaedic Implants, Dental Implants, Ophthalmic Implants, and Other Implants)
  • 5.2.2.By Material (Biomaterial Metal Alloys, Ceramics, Polymers, and Other Materials)
  • 5.2.3.By End User (Hospitals Clinics, Ambulatory Surgical Centres, Others)
  • 5.2.4.By Region
  • 5.2.5.By Company (2023)
• 5.3.Market Map

6.North America Bio-Implants Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.ByProduct Type
  • 6.2.2.By Material
  • 6.2.3.By End User
  • 6.2.4.By Country
• 6.3.North America: Country Analysis
  • 6.3.1.United States Bio-Implants Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Product Type
      • 6.3.1.2.2.By Material
      • 6.3.1.2.3.By End User
  • 6.3.2.Canada Bio-Implants Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Product Type
      • 6.3.2.2.2.By Material
      • 6.3.2.2.3.By End User
  • 6.3.3.Mexico Bio-Implants Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Product Type
      • 6.3.3.2.2.By Material
      • 6.3.3.2.3.By End User

7.Europe Bio-Implants Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Product Type
  • 7.2.2.By Material
  • 7.2.3.By End User
  • 7.2.4.By Country
• 7.3.Europe: Country Analysis
  • 7.3.1.Germany Bio-Implants Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Product Type
      • 7.3.1.2.2.By Material
      • 7.3.1.2.3.By End User
  • 7.3.2.United Kingdom Bio-Implants Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Product Type
      • 7.3.2.2.2.By Material
      • 7.3.2.2.3.By End User
  • 7.3.3.Italy Bio-Implants Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecasty
      • 7.3.3.2.1.By Product Type
      • 7.3.3.2.2.By Material
      • 7.3.3.2.3.By End User
  • 7.3.4.France Bio-Implants Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Product Type
      • 7.3.4.2.2.By Material
      • 7.3.4.2.3.By End User
  • 7.3.5.Spain Bio-Implants Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Product Type
      • 7.3.5.2.2.By Material
      • 7.3.5.2.3.By End User

8.Asia-Pacific Bio-Implants Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Product Type
  • 8.2.2.By Material
  • 8.2.3.By End User
  • 8.2.4.By Country
• 8.3.Asia-Pacific: Country Analysis
  • 8.3.1.China Bio-Implants Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Product Type
      • 8.3.1.2.2.By Material
      • 8.3.1.2.3.By End User
  • 8.3.2.India Bio-Implants Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Product Type
      • 8.3.2.2.2.By Material
      • 8.3.2.2.3.By End User
  • 8.3.3.Japan Bio-Implants Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Product Type
      • 8.3.3.2.2.By Material
      • 8.3.3.2.3.By End User
  • 8.3.4.South Korea Bio-Implants Market Outlook
    • 8.3.4.1.Market Size Forecast
      • 8.3.4.1.1.By Value
    • 8.3.4.2.Market Share Forecast
      • 8.3.4.2.1.By Product Type
      • 8.3.4.2.2.By Material
      • 8.3.4.2.3.By End User
  • 8.3.5.Australia Bio-Implants Market Outlook
    • 8.3.5.1.Market Size Forecast
      • 8.3.5.1.1.By Value
    • 8.3.5.2.Market Share Forecast
      • 8.3.5.2.1.By Product Type
      • 8.3.5.2.2.By Material
      • 8.3.5.2.3.By End User

9.South America Bio-Implants Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Product Type
  • 9.2.2.By Material
  • 9.2.3.By End User
  • 9.2.4.By Country
• 9.3.South America: Country Analysis
  • 9.3.1.Brazil Bio-Implants Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Product Type
      • 9.3.1.2.2.By Material
      • 9.3.1.2.3.By End User
  • 9.3.2.Argentina Bio-Implants Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Product Type
      • 9.3.2.2.2.By Material
      • 9.3.2.2.3.By End User
  • 9.3.3.Colombia Bio-Implants Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Product Type
      • 9.3.3.2.2.By Material
      • 9.3.3.2.3.By End User

10.Middle East and Africa Bio-Implants Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value
• 10.2.Market Share Forecast
  • 10.2.1.By Product Type
  • 10.2.2.By Material
  • 10.2.3.By End User
  • 10.2.4.By Country
• 10.3.MEA: Country Analysis
  • 10.3.1.South Africa Bio-Implants Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Product Type
      • 10.3.1.2.2.By Material
      • 10.3.1.2.3.By End User
  • 10.3.2.Saudi Arabia Bio-Implants Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Product Type
      • 10.3.2.2.2.By Material
      • 10.3.2.2.3.By End User
  • 10.3.3.UAE Bio-Implants Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Product Type
      • 10.3.3.2.2.By Material
      • 10.3.3.2.3.By End User

11.Market Dynamics

• 11.1.Drivers
• 11.2.Challenges

12.Market Trends Developments

• 12.1.Recent Development
• 12.2.Mergers Acquisitions
• 12.3.Product Launches

13.Global Bio-Implants Market: SWOT Analysis

14.Porter's Five Forces Analysis

• 14.1.Competition in the Industry
• 14.2.Potential of New Entrants
• 14.3.Power of Suppliers
• 14.4.Power of Customers
• 14.5.Threat of Substitute Products

15.Competitive Landscape

• 15.1.BIOTRONIK SE Co. KG
  • 15.1.1.Business Overview
  • 15.1.2.Company Snapshot
  • 15.1.3.Products Services
  • 15.1.4.Financials (As Reported)
  • 15.1.5.Recent Developments
  • 15.1.6.Key Personnel Details
  • 15.1.7.SWOT Analysis
• 15.2.Invibio Limited
• 15.3.Wright MedicalGroup N.V.
• 15.4.Edwards Lifesciences Corporation
• 15.5.MiMeDX Group Inc.
• 15.6.Stryker Corporation
• 15.7.Endo International plc
• 15.8.Smith Nephews plc
• 15.9.Zimmer Biomet Holdings Inc
• 15.10.Ethicon Inc.

16.Strategic Recommendations

17.About Us Disclaimer